Back to Search
Start Over
Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma.
- Source :
-
Haematologica [Haematologica] 2016 Apr; Vol. 101 (4), pp. e149-52. Date of Electronic Publication: 2015 Dec 11. - Publication Year :
- 2016
- Subjects :
- Aged
Aged, 80 and over
Drug Administration Schedule
Drug Dosage Calculations
Female
Humans
Lenalidomide
Logistic Models
Male
Maximum Tolerated Dose
Middle Aged
Multiple Myeloma complications
Multiple Myeloma mortality
Multiple Myeloma pathology
Neoplasms, Second Primary complications
Neoplasms, Second Primary mortality
Neoplasms, Second Primary pathology
Recurrence
Survival Analysis
Thalidomide therapeutic use
Treatment Outcome
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bortezomib therapeutic use
Dexamethasone therapeutic use
Multiple Myeloma drug therapy
Neoplasms, Second Primary drug therapy
Thalidomide analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 101
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Report
- Accession number :
- 26659914
- Full Text :
- https://doi.org/10.3324/haematol.2015.132431